Is Amedisys, Inc. (AMED) a Buy, Sell, or Hold?
NASDAQ : AMED
Amedisys, Inc. — Analyst Ratings
$100.99 USD
$0.01 (0.01%)
- Volume
- 1.04M
- Average Volume
- 517.9K
- Market Capitalization
- $3.32B
- P/E Ratio
- 25.76
- Dividend Yield
- 0.00%
- Price Target
- $162.50
- Year High
- $101.02
- Year Low
- $82.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.36
Analyst Consensus Summary
Consensus Rating
N/A
28 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
-37.9%
vs Current Price
Price Target
$162.50
Average TargetPrice Target Range
Lowest Target
$85.00
18.8% UPSIDE
Average Target
$162.50
Median Estimate
Highest Target
$190.00
-46.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 28
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 18 | 2 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Frank Morgan | $100 | $92.16 | 2024-03-25 05:41 AM | 8.5% |
| Jefferies | Brian Tanquilut | $90.8 | $91.28 | 2023-07-06 04:43 AM | -0.5% |
| Truist Financial | David MacDonald | $150 | $128.18 | 2022-07-26 03:45 PM | 17.0% |
| Deutsche Bank | Justin Bowers | $175 | $110.82 | 2022-07-03 03:23 PM | 57.9% |
| BMO Capital | Matthew Borsch | $190 | $159.9 | 2022-02-24 07:00 PM | 18.8% |